1. Home
  2. UAMY vs IVA Comparison

UAMY vs IVA Comparison

Compare UAMY & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United States Antimony Corporation

UAMY

United States Antimony Corporation

HOLD

Current Price

$10.77

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.64

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAMY
IVA
Founded
1968
2011
Country
United States
France
Employees
N/A
77
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
UAMY
IVA
Price
$10.77
$5.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$9.44
$16.20
AVG Volume (30 Days)
9.9M
490.5K
Earning Date
05-07-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,257,708.00
N/A
Revenue This Year
$219.89
N/A
Revenue Next Year
$104.28
$751.20
P/E Ratio
N/A
N/A
Revenue Growth
162.80
N/A
52 Week Low
$1.94
$2.94
52 Week High
$19.71
$7.98

Technical Indicators

Market Signals
Indicator
UAMY
IVA
Relative Strength Index (RSI) 60.29 48.15
Support Level $10.68 $5.04
Resistance Level $11.01 $5.78
Average True Range (ATR) 0.86 0.37
MACD 0.24 0.04
Stochastic Oscillator 79.36 76.97

Price Performance

Historical Comparison
UAMY
IVA

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: